1-(Heterocyclylalkyl)-1,3-dihydro-2-H-benzimidazole-2-ones

Details 1-(Heterocyclylalkyl)-1,3-dihydro-2-H-benzimidazole-2-ones 1-(Heterocyclylalkyl)-1,3-dihydro-2-H-benzimidazole-2-ones

1978-12-14

1980-01-01

Rotman, Alan L.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

26032634, 2603265S, 2603265CA, 2603423, 26034843, 26034844, 26034845, 26034846, 26034858, 424267, 424273R, 546271, 546329, 546338, 548305, C07D40514, C07D40106, C07D40306

Patent

active

041818024

ABSTRACT:
Novel 1-(heterocyclylalkyl)-1,3-dihydro-2H-benzimidazol-2-ones, wherein said heterocyclyl group is a 3-pyrrolidinyl or 3-piperidinyl group, each substituted in the 1-position with a 3-aryloxy-2-hydroxypropyl, 3-arylthio-2-hydroxypropyl or 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-2-hydroxyethyl group, said compounds having useful .beta.-adrenergic receptor blocking activity.

REFERENCES:
patent: 3818017 (1974-06-01), Janssen et al.
patent: 3894030 (1975-07-01), Janssen et al.
patent: 3910930 (1975-10-01), Janssen et al.

Affiliated with

Also associated with

Rating

1-(Heterocyclylalkyl)-1,3-dihydro-2-H-benzimidazole-2-ones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-(Heterocyclylalkyl)-1,3-dihydro-2-H-benzimidazole-2-ones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(Heterocyclylalkyl)-1,3-dihydro-2-H-benzimidazole-2-ones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2120943